IL163865A0 - Compositions comprising a non-ionicsurfactant and n-docosanol - Google Patents

Compositions comprising a non-ionicsurfactant and n-docosanol

Info

Publication number: IL163865A0
Authority: IL; Israel
Prior art keywords: alcohol; docosanol; active ingredient; compositions; nonionic surfactant
Prior art date: 1996-09-17

Application number

IL16386597A

Other languages

English (en)

Original Assignee

Avanir Pharmaceuticals

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-17

Filing date

1997-09-10

Publication date

2005-12-18

1997-08-22 Priority claimed from US08/916,624 external-priority patent/US5952392A/en

1997-09-10 Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals

2005-12-18 Publication of IL163865A0 publication Critical patent/IL163865A0/xx

Links

NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 4
239000002736 nonionic surfactant Substances 0.000 title abstract 3
239000004480 active ingredient Substances 0.000 abstract 2
HOWGUJZVBDQJKV-UHFFFAOYSA-N docosane Chemical compound CCCCCCCCCCCCCCCCCCCCCC HOWGUJZVBDQJKV-UHFFFAOYSA-N 0.000 abstract 2
UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 abstract 2
BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 abstract 2
GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 abstract 2
CFOQKXQWGLAKSK-KTKRTIGZSA-N (13Z)-docosen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCO CFOQKXQWGLAKSK-KTKRTIGZSA-N 0.000 abstract 1
CFOQKXQWGLAKSK-UHFFFAOYSA-N 13-docosen-1-ol Natural products CCCCCCCCC=CCCCCCCCCCCCCO CFOQKXQWGLAKSK-UHFFFAOYSA-N 0.000 abstract 1
UAUDZVJPLUQNMU-UHFFFAOYSA-N Erucasaeureamid Natural products CCCCCCCCC=CCCCCCCCCCCCC(N)=O UAUDZVJPLUQNMU-UHFFFAOYSA-N 0.000 abstract 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
235000021355 Stearic acid Nutrition 0.000 abstract 1
229940009976 deoxycholate Drugs 0.000 abstract 1
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical group C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
UAUDZVJPLUQNMU-KTKRTIGZSA-N erucamide Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(N)=O UAUDZVJPLUQNMU-KTKRTIGZSA-N 0.000 abstract 1
GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 abstract 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 abstract 1
239000008117 stearic acid Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Biotechnology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fats And Perfumes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

IL16386597A 1996-09-17 1997-09-10 Compositions comprising a non-ionicsurfactant and n-docosanol IL163865A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US71500996A	1996-09-17	1996-09-17
US08/916,624 US5952392A (en)	1996-09-17	1997-08-22	Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
PCT/US1997/016007 WO1998011887A2 (en)	1996-09-17	1997-09-10	Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides

Publications (1)

Publication Number	Publication Date
IL163865A0 true IL163865A0 (en)	2005-12-18

Family

ID=27109257

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL16386597A IL163865A0 (en)	1996-09-17	1997-09-10	Compositions comprising a non-ionicsurfactant and n-docosanol
IL12903397A IL129033A0 (en)	1996-09-17	1997-09-10	Viral inhibition by long-chain alcohols alkanes fatty acids and amides

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL12903397A IL129033A0 (en)	1996-09-17	1997-09-10	Viral inhibition by long-chain alcohols alkanes fatty acids and amides

Country Status (16)

Country	Link
EP (2)	EP1557167A1 (de)
JP (1)	JP3739098B2 (de)
KR (2)	KR100528815B1 (de)
CN (1)	CN1213748C (de)
AT (1)	ATE299700T1 (de)
AU (1)	AU742929B2 (de)
BR (1)	BR9711501A (de)
CA (1)	CA2273960C (de)
DE (1)	DE69733778T2 (de)
DK (1)	DK1001759T3 (de)
ES (1)	ES2245004T3 (de)
IL (2)	IL163865A0 (de)
MX (1)	MXPA99002575A (de)
PL (1)	PL189618B1 (de)
PT (1)	PT1001759E (de)
WO (1)	WO1998011887A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6440980B1 (en) *	1996-09-17	2002-08-27	Avanir Pharmaceuticals	Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
DE69739583D1 (de)	1996-11-14	2009-10-29	Lipomedica Ehf	Topische zusammensetzungen enthaltend als therapeutisch aktiven wirkstoff ein monoglycerid zur behandlung von schleimhautinfektionen
ES2202872T3 (es)	1997-06-20	2004-04-01	Prometics Bodycare Limited	Composicion protectora de la piel.
IL142535A0 (en) *	2001-04-11	2002-03-10	Yeda Res & Dev	Pharmaceutical compositions for the treatment of inflammation
SE0102289D0 (sv) *	2001-06-27	2001-06-27	Anders Hamberger	New use of compound
CA2421026C (en) *	2001-10-16	2005-02-15	Avanir Pharmaceuticals	Viral inhibition by n-docosanol
CN100582085C (zh)	2002-10-10	2010-01-20	耶达研究及发展有限公司	脂肪醇的碱性酯及它们作为抗炎药或免疫调节剂的用途
KR200449517Y1 (ko) *	2008-01-23	2010-07-15	김영중	선박의 조향장치용 헬름
KR100971276B1 (ko) *	2008-05-29	2010-07-20	김영중	조향장치
WO2011112997A1 (en)	2010-03-11	2011-09-15	Chemic Laboratories, Inc.	Novel compositions and methods
CN102702061B (zh) *	2012-06-07	2013-04-24	浙江维康药业有限公司	一种盐酸水苏碱化合物及含有该化合物的药物组合物
JP6125962B2 (ja) *	2013-09-24	2017-05-10	株式会社デンソー	抗ウイルス剤
FR3080038B1 (fr) *	2018-04-16	2020-10-09	Oreal	Composition cosmetique pour fibres keratiniques
FR3080034B1 (fr) *	2018-04-16	2020-04-24	L'oreal	Composition cosmetique pour fibres keratiniques
KR102611242B1 (ko) *	2021-05-17	2023-12-08	충남대학교 산학협력단	알케인을 유효성분으로 함유하는 항바이러스용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3421468A1 (de) *	1984-06-08	1985-12-19	Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim	Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US5208257A (en) *	1986-04-21	1993-05-04	Kabara Jon J	Topical antimicrobial pharmaceutical compositions and methods
US5194451A (en) *	1989-11-02	1993-03-16	Katz David H	Systemic anti-inflammatory treatment
US5250236A (en) *	1991-08-05	1993-10-05	Gasco Maria R	Method for producing solid lipid microspheres having a narrow size distribution
CA2153780C (en) *	1993-01-15	2004-04-13	Micro Vesicular Systems, Inc.	Method of inhibiting viral reproduction
ATE399004T1 (de) *	1993-12-13	2008-07-15	Avanir Pharmaceuticals	Formulierungen aus c-20 bis c-28 alkoholen und saccharoseestern

1997
- 1997-09-10 DK DK97941503T patent/DK1001759T3/da active
- 1997-09-10 PL PL97332455A patent/PL189618B1/pl unknown
- 1997-09-10 CA CA002273960A patent/CA2273960C/en not_active Expired - Lifetime
- 1997-09-10 EP EP05075320A patent/EP1557167A1/de not_active Withdrawn
- 1997-09-10 KR KR10-1999-7002271A patent/KR100528815B1/ko not_active Expired - Fee Related
- 1997-09-10 DE DE69733778T patent/DE69733778T2/de not_active Expired - Lifetime
- 1997-09-10 BR BR9711501-0A patent/BR9711501A/pt not_active Application Discontinuation
- 1997-09-10 AU AU43397/97A patent/AU742929B2/en not_active Ceased
- 1997-09-10 ES ES97941503T patent/ES2245004T3/es not_active Expired - Lifetime
- 1997-09-10 IL IL16386597A patent/IL163865A0/xx unknown
- 1997-09-10 EP EP97941503A patent/EP1001759B1/de not_active Expired - Lifetime
- 1997-09-10 AT AT97941503T patent/ATE299700T1/de active
- 1997-09-10 PT PT97941503T patent/PT1001759E/pt unknown
- 1997-09-10 CN CNB971998051A patent/CN1213748C/zh not_active Expired - Fee Related
- 1997-09-10 MX MXPA99002575A patent/MXPA99002575A/es unknown
- 1997-09-10 IL IL12903397A patent/IL129033A0/xx not_active IP Right Cessation
- 1997-09-10 WO PCT/US1997/016007 patent/WO1998011887A2/en not_active Ceased
- 1997-09-10 JP JP51473498A patent/JP3739098B2/ja not_active Expired - Fee Related
- 1997-09-10 KR KR10-2002-7011861A patent/KR100528816B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE299700T1 (de)	2005-08-15
AU4339797A (en)	1998-04-14
WO1998011887A2 (en)	1998-03-26
KR20030097605A (ko)	2003-12-31
DE69733778T2 (de)	2006-04-20
EP1557167A1 (de)	2005-07-27
DE69733778D1 (de)	2005-08-25
CA2273960C (en)	2003-12-30
JP2001521490A (ja)	2001-11-06
PT1001759E (pt)	2005-10-31
CN1244121A (zh)	2000-02-09
AU742929B2 (en)	2002-01-17
PL332455A1 (en)	1999-09-13
MXPA99002575A (es)	2004-07-29
DK1001759T3 (da)	2005-10-10
BR9711501A (pt)	2004-05-25
KR100528816B1 (ko)	2005-11-16
EP1001759A2 (de)	2000-05-24
KR100528815B1 (ko)	2005-11-16
PL189618B1 (pl)	2005-08-31
ES2245004T3 (es)	2005-12-16
IL129033A0 (en)	2000-02-17
JP3739098B2 (ja)	2006-01-25
CN1213748C (zh)	2005-08-10
CA2273960A1 (en)	1998-03-26
EP1001759B1 (de)	2005-07-20
KR20000036210A (ko)	2000-06-26
WO1998011887A3 (en)	1998-06-25

Publication	Publication Date	Title
EP0264904A3 (de)	1988-08-17	Benzoylharnstoff-Derivate enthaltende Arzneimittel
IL129033A0 (en)	2000-02-17	Viral inhibition by long-chain alcohols alkanes fatty acids and amides
NZ241169A (en)	1995-01-27	Substituted azole derivatives, preparatory processes and pharmaceutical compositions
CA2183972A1 (en)	1995-09-21	Oxazolidinone derivatives and pharmaceutical compositions containing them
NZ509328A (en)	2002-11-26	Medicinal aerosol formulations
NO20025821L (no)	2003-02-04	2-aminokarbonyl-9H-purinderivater
EP0368388A3 (de)	1991-07-17	3-Piperidinyl-1,2-benzisoxazole
MY121192A (en)	2006-01-28	New compounds.
EP1208846A3 (de)	2003-04-16	Nichtwässrige polar-aprotische Peptidformulierungen
CA2244785A1 (en)	1997-08-28	Pentafluorobenzenesulfonamides and analogs
IL98133A0 (en)	1992-06-21	Sulphonyl substituted benzo-naphthyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CA2237189A1 (en)	1997-07-17	3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
NZ236605A (en)	1992-08-26	2-aminopyrimidine-4-carboxamide derivatives, preparation and pharmaceutical compositions thereof
MY128392A (en)	2007-01-31	6ALPHA, 9ALPHA-DIFLUORO-17ALPHA-(2-FURANYLCARBOXYL)OXY]-11ß-HYDROXY-16ALPHA-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
KR960703863A (ko)	1996-08-31	암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
CA2063273A1 (en)	1991-01-12	Surfactant compositions and methods
UA74388C2 (uk)	2005-12-15	Фармацевтичні композиції тизоксаніду і нітазоксаніду
ES8401944A1 (es)	1984-01-01	Procedimiento para la preparacion de derivados de acido salicilico.
CA2339193A1 (en)	2000-02-17	Pharmaceutical compositions comprising ibuprofen and domperidone
MY137475A (en)	2009-01-30	Chemical compounds.
EP0421102A3 (en)	1992-02-26	Substituted acrylic acid esters
SG48821A1 (en)	1998-05-18	N-[[1-[4-(4-fluorophenoxy)butyl]-4-piperidinyl]-N- methylamino] 2-benzothiazolols as class III antiarrhythmic agents
AU2003267551A1 (en)	2004-03-11	Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
ATE282608T1 (de)	2004-12-15	Chinoxalindionen
EP1486203A3 (de)	2005-03-16	Oberflächenaktive Verbindungen und ihre Anwendungen